Endothelial function changes in paroxysmal atrial fibrillation and treatment with propafenone

Aim. To evaluate the changes of endothelial function in arterial hypertension (AH) patients with paroxysmal atrial fibrillation (AF) in treatment with propafenone (Propanorm, PRO.MED.CS Praha a. s.) in comparison with bisoprolol.Material and methods. To the study, 62 AH patients included with paroxy...

Full description

Saved in:
Bibliographic Details
Main Authors: V. I. Podzolkov, A. I. Tarzimanova
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2018-08-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/885
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849408486882934784
author V. I. Podzolkov
A. I. Tarzimanova
author_facet V. I. Podzolkov
A. I. Tarzimanova
author_sort V. I. Podzolkov
collection DOAJ
description Aim. To evaluate the changes of endothelial function in arterial hypertension (AH) patients with paroxysmal atrial fibrillation (AF) in treatment with propafenone (Propanorm, PRO.MED.CS Praha a. s.) in comparison with bisoprolol.Material and methods. To the study, 62 AH patients included with paroxysmal AH, age 45-63 y. o. (mean age 54,5±3,7 y. o.). Patients were randomized to 2 groups: 32 of group 1 (main) for rhythm-control were taking propafenone (Propanorm, PRO.MED.CS Praha a. s.) 450 mg daily, and 30 of group 2 (comparison) were taking bisoprolol for rate control. The groups were comparable by gender, age, severity of AH and duration of arrhythmia. Changes in endothelium vascular motion function and biochemical markers of endothelial dysfunction were assessed at inclusion and in 12 months of therapy.Results. Sinus rhythm retention in propafenone group facilitated the improvement of vascular motion function of endothelium — endothelium dependent vasodilatation of brachial artery showed tendency to rise significantly from 5,4±0,3% to 6,9±0,1% (р=0,01). In patients taking bisoprolol for pulse reduction during 12 months, there was negative tendency from 4,8±0,2% to 3,6±0,1% (р=0,003), that points on worsening of endothelial function with persistent AF. Repeat measurement of biochemical markers of endothelial dysfunction revealed that in 12 months there is raise of endothelin concentration in both groups. Value of the collagen-binding activeness of von Willebrand factor in 12 months significantly reduced from 131±12 to 118±6 U/dL (р<0,05) in those retaining sinus rhythm with propafenone, and increased from 135±11 U/dL to 147±12 U/dL in those with rate control by bisoprolol.Conclusion. In AH patients with paroxysmal AF retention of sinus rhythm with propafenone facilitated the improvement of vascular motion function of endothelium and decrease of collagen binding activeness of von Willebrand factor.
format Article
id doaj-art-2ee8328e62914579bb7def6fa4d56b1a
institution Kabale University
issn 1728-8800
2619-0125
language Russian
publishDate 2018-08-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-2ee8328e62914579bb7def6fa4d56b1a2025-08-20T03:35:47Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252018-08-01174404510.15829/1728-8800-2018-4-40-45593Endothelial function changes in paroxysmal atrial fibrillation and treatment with propafenoneV. I. Podzolkov0A. I. Tarzimanova1First Sechenov Moscow State Medical University of the Ministry of Health (the Sechenov University)First Sechenov Moscow State Medical University of the Ministry of Health (the Sechenov University)Aim. To evaluate the changes of endothelial function in arterial hypertension (AH) patients with paroxysmal atrial fibrillation (AF) in treatment with propafenone (Propanorm, PRO.MED.CS Praha a. s.) in comparison with bisoprolol.Material and methods. To the study, 62 AH patients included with paroxysmal AH, age 45-63 y. o. (mean age 54,5±3,7 y. o.). Patients were randomized to 2 groups: 32 of group 1 (main) for rhythm-control were taking propafenone (Propanorm, PRO.MED.CS Praha a. s.) 450 mg daily, and 30 of group 2 (comparison) were taking bisoprolol for rate control. The groups were comparable by gender, age, severity of AH and duration of arrhythmia. Changes in endothelium vascular motion function and biochemical markers of endothelial dysfunction were assessed at inclusion and in 12 months of therapy.Results. Sinus rhythm retention in propafenone group facilitated the improvement of vascular motion function of endothelium — endothelium dependent vasodilatation of brachial artery showed tendency to rise significantly from 5,4±0,3% to 6,9±0,1% (р=0,01). In patients taking bisoprolol for pulse reduction during 12 months, there was negative tendency from 4,8±0,2% to 3,6±0,1% (р=0,003), that points on worsening of endothelial function with persistent AF. Repeat measurement of biochemical markers of endothelial dysfunction revealed that in 12 months there is raise of endothelin concentration in both groups. Value of the collagen-binding activeness of von Willebrand factor in 12 months significantly reduced from 131±12 to 118±6 U/dL (р<0,05) in those retaining sinus rhythm with propafenone, and increased from 135±11 U/dL to 147±12 U/dL in those with rate control by bisoprolol.Conclusion. In AH patients with paroxysmal AF retention of sinus rhythm with propafenone facilitated the improvement of vascular motion function of endothelium and decrease of collagen binding activeness of von Willebrand factor.https://cardiovascular.elpub.ru/jour/article/view/885atrial fibrillationpropafenoneendothelium function changes
spellingShingle V. I. Podzolkov
A. I. Tarzimanova
Endothelial function changes in paroxysmal atrial fibrillation and treatment with propafenone
Кардиоваскулярная терапия и профилактика
atrial fibrillation
propafenone
endothelium function changes
title Endothelial function changes in paroxysmal atrial fibrillation and treatment with propafenone
title_full Endothelial function changes in paroxysmal atrial fibrillation and treatment with propafenone
title_fullStr Endothelial function changes in paroxysmal atrial fibrillation and treatment with propafenone
title_full_unstemmed Endothelial function changes in paroxysmal atrial fibrillation and treatment with propafenone
title_short Endothelial function changes in paroxysmal atrial fibrillation and treatment with propafenone
title_sort endothelial function changes in paroxysmal atrial fibrillation and treatment with propafenone
topic atrial fibrillation
propafenone
endothelium function changes
url https://cardiovascular.elpub.ru/jour/article/view/885
work_keys_str_mv AT vipodzolkov endothelialfunctionchangesinparoxysmalatrialfibrillationandtreatmentwithpropafenone
AT aitarzimanova endothelialfunctionchangesinparoxysmalatrialfibrillationandtreatmentwithpropafenone